ML329

• Description :

  ML329 is a micropthalmia-associated transcription factor (MITF) inhibitor, which inhibits TRPM-1 promoter activity with an IC50 of 1.2 μM.

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Others

• Type :

  Reference compound

• Related Pathways :

  Others

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/ML329.html

• Concentration :

  10mM

• Purity :

  98.0

• Solubility :

  DMF : 5 mg/mL (ultrasonic) |DMSO : 5 mg/mL (ultrasonic)

• Smiles :

  O=S(C1=CC=C(NC(C2=O)=CC(C3=C2C=CC=C3)=O)C=C1)(N)=O

• Molecular Formula :

  C16H12N2O4S

• Molecular Weight :

  328.34

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Faloon PW, et al. A Small Molecule Inhibitor of the MITF Molecular Pathway. Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD) : National Center for Biotechnology Information (US) ; 2010-2012 Dec 13.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [19992-50-8]